Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Dec 2014

Garcia Christine, Lyon Liisa, Littell Ramey D, Powell C Bethan

Abstract excerpt

PURPOSE: The aim of this article is to describe cancer risk-reducing behaviors of women with BRCA variants of unknown significance. METHODS: A retrospective chart review from 1995 to 2012 identified women with BRCA mutations in a northern California community system. Exclusion criteria included loss of membership/death within 1 year of testing, prior ovarian cancer, or bilateral salpingo-oophorectomy. Primary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Health Behavior

Share to Mastectomy

Share to Odds Ratio

Share to Ovariectomy

Share to Risk Management

Source

Identifiers

PMID: 24854227
DOI: 10.1038/gim.2014.48

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.PMID 24854227Read ↗

Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions.Semantic proximity Read ↗

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.Semantic proximity Read ↗

Risk management decisions in women with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Risk management options elected by women after testing positive for a BRCA mutation.Semantic proximity Read ↗

Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.Semantic proximity Read ↗

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.Semantic proximity Read ↗

Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.Semantic proximity Read ↗

Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system.Semantic proximity Read ↗

Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Semantic proximity Read ↗

Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.